Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Atomo Diagnostics Ltd. ( (AU:AT1) ) is now available.
Atomo Diagnostics Limited has released its FY25 financial results and will host a webinar for analysts and investors on September 2, 2025. The company continues to focus on expanding its presence in the global diagnostic market with its innovative rapid diagnostic test devices, which have been successfully commercialized internationally.
More about Atomo Diagnostics Ltd.
Atomo is an Australian-headquartered medical device company that supplies unique, integrated rapid diagnostic test (RDT) devices to the global diagnostic market. Its patented devices enhance usability and reliability in rapid point-of-care and at-home testing, with commercialized products targeting infectious diseases such as COVID-19, HIV, and others.
Average Trading Volume: 1,613,369
Technical Sentiment Signal: Hold
Current Market Cap: A$14.58M
Learn more about AT1 stock on TipRanks’ Stock Analysis page.